Genprex Inc.

GNPX | NASDAQ

Price Alert Chart Builder DCF Calculator

$3.48

+$0.03 (+0.87%)

At close: Sep 21, 2026, 4:00 PM ET

$3.50

+$0.02 (+0.57%)

Pre-market: Sep 22, 2026, 6:11 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+0.87%

(1D)

Rating

Updated: Sep 5, 2026

19.5

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $1.76M

1D Range

3.47 3.63

52W Range

3.26 1,210

Valuation (TTM)

PE -0.02

PB 0.12

EV/EBITDA 0.85

Valuation (NTM)

Forward PE N/A

Forward PEG -0.00

Price Target N/A

Cash Flow

FCF Yield -885.7%

SBC Adj. FCF Yield -891.8%

SBC Impact -0.7%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y 130.6% | 47.1%

FCF 3Y | 5Y 15.9% | 4.9%

Returns

ROA -96.3%

ROE -163.1%

ROIC -107.1%

Financial Health

Net Cash

$15.15M

Current Ratio 6.77

Interest Coverage -34.78

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Genprex, Inc. is a biotechnology firm specializing in gene therapy, with its primary focus on advancing treatments through clinical stages. Their mission revolves around developing innovative therapie...

Sector Healthcare

Industry Biotechnology

Employees 13

IPO Date Mar 28, 2018

Website www.genprex.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.